BamSEC and AlphaSense Join Forces
Learn More

Sotera Health Company

NASDAQ: SHC    
Share price (11/22/24): $12.82    
Market cap (11/22/24): $3.631 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 237 pages Recitals
12/34/56
EX-10.1
from 8-K 217 pages Recitals
12/34/56
EX-10.7
from 10-K 3 pages Material contract
12/34/56
EX-10.3
from 10-Q 8 pages Sotera Health Company Restrictive Covenants Agreement
12/34/56
EX-10.2
from 10-Q 3 pages Material contract
12/34/56
EX-10.1
from 8-K 205 pages Recitals
12/34/56
EX-10.3
from 10-Q 82 pages [Certain Portions of This Exhibit Have Been Redacted Pursuant to Item 601(b)(10)(iv) of Regulation S-K and Marked With Asterisks. the Omitted Information Is (I) Not Material and (II) the Type That the Registrant Treats as Private or Confidential.] Willowbrook Group Settlement Agreement Between and Among Plaintiffs’ Executive Committee (As Defined Herein) and Sotera Health (As Defined Herein) and Sterigenics US
12/34/56
EX-10.2
from 10-Q 73 pages [Certain Portions of This Exhibit Have Been Redacted Pursuant to Item 601(b)(10)(iv) of Regulation S-K and Marked With Asterisks. the Omitted Information Is (I) Not Material and (II) the Type That the Registrant Treats as Private or Confidential.] Settlement Agreement Between and Among Plaintiffs’ Counsel (As Defined Herein) and Sotera Health (As Defined Herein) and Sterigenics US
12/34/56
EX-10.1
from 8-K 223 pages Recitals
12/34/56
EX-10.49
from 10-K 9 pages Sotera Health Company 2020 Omnibus Incentive Plan Restricted Stock Unit Grant Notice
12/34/56
EX-10.48
from 10-K 9 pages Sotera Health Company 2020 Omnibus Incentive Plan Stock Option Grant Notice
12/34/56
EX-10.47
from 10-K 8 pages [Certain Portions of This Exhibit Have Been Redacted Pursuant to Item 601(b)(10)(iv) of Regulation S-K and Marked With Asterisks. the Omitted Information Is (I) Not Material and (II) the Type That the Registrant Treats as Private or Confidential.] Willowbrook: Trial Plaintiffs Settlement Term Sheet
12/34/56
EX-10.46
from 10-K 47 pages [Certain Portions of This Exhibit Have Been Redacted Pursuant to Item 601(b)(10)(iv) of Regulation S-K and Marked With Asterisks. the Omitted Information Is (I) Not Material and (II) the Type That the Registrant Treats as Private or Confidential.] Willowbrook: Group Settlement Term Sheet
12/34/56
EX-10.45
from 10-K 3 pages Trademark Security Agreement, Dated as of February 23, 2023 (This “Agreement”), Among Sotera Health Holdings, LLC (The “Grantor”) and Jpmorgan Chase Bank, N.A., as Collateral Agent (In Such Capacity and Together With Its Successors and Assigns, the “First Lien Collateral Agent”)
12/34/56
EX-10.44
from 10-K 3 pages Trademark Security Agreement, Dated as of February 23, 2023 (This “Agreement”), Among Regulatory Compliance Associates Inc. (The “Grantor”) and Jpmorgan Chase Bank, N.A., as Collateral Agent (In Such Capacity and Together With Its Successors and Assigns, the “First Lien Collateral Agent”)
12/34/56
EX-10.43
from 10-K 3 pages Trademark Security Agreement, Dated as of February 23, 2023 (This “Agreement”), Among Nelson Laboratories Bozeman, LLC (The “Grantor”) and Jpmorgan Chase Bank, N.A., as Collateral Agent (In Such Capacity, and Together With Its Successors and Assigns, the “First Lien Collateral Agent”)
12/34/56
EX-10.42
from 10-K 3 pages Copyright Security Agreement, Dated as of February 23, 2023 (This “Agreement”), Among Nelson Laboratories, LLC (The “Grantor”) and Jpmorgan Chase Bank, N.A., as Collateral Agent (In Such Capacity and Together With Its Successors and Assigns, the “First Lien Collateral Agent”)
12/34/56
EX-10.40
from 10-K 30 pages First Lien Collateral Agreement Dated as of February 23, 2023, Among Sotera Health Company (F/K/a Sotera Health Topco, Inc.), as Holdings, Sotera Health Holdings, LLC, as Borrower, the Other Grantors Party Hereto, and Jpmorgan Chase Bank, N.A., as First Lien Collateral Agent
12/34/56
EX-10.39
from 10-K 17 pages First Lien Guarantee Agreement
12/34/56
EX-10.37
from 10-K 12 pages Recitals
12/34/56